RNA, U7 small nuclear 171 pseudogeneGenealiases: []
Q-omics provides the consensus-scored RNU7-171P profile across patient tissues and cancer cell-line models. RNU7-171P expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in BLCA. Among the 18 cancer types available for tumor–normal comparison, RNU7-171P is differentially expressed in 8, with the highest sampling consensus in LUAD. Additionally, RNU7-171P RNA expression shows 13,805 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight BLCA, LUAD, and UVM as cancer lineages where RNU7-171P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNU7-171P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNU7-171P survival associations across molecular data types. RNU7-171P RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNU7-171P RNA expression–survival associations across cancer types. High RNU7-171P expression shows unfavorable associations in ACC and UVM, but favorable associations in BLCA, PAAD, MESO and LUAD. The BLCA Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify BLCA as the clearest survival context for RNU7-171P RNA expression.
This table summarizes RNU7-171P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in LUAD for RNA.
This table ranks reproducible tumor–normal expression differences for RNU7-171P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNU7-171P shows lower tumor expression in LUAD, LUSC, KICH, BLCA and UCEC and higher tumor expression in ESCA. The LUAD box plot shows higher RNU7-171P RNA expression in normal versus tumor tissue (log2 FC = −1.258, t-test p < 0.001).
This table shows molecular features associated with RNU7-171P in patient tissues and cancer cell lines. In patient samples, RNU7-171P shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
